pasireotide
| SMILES | NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)C[C@@H](C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2 |
| InChIKey | VMZMNAABQBOLAK-DBILLSOUSA-N |
| Sequence | XXWKYF |
Chemical properties
| Hydrogen bond acceptors | 11 |
| Hydrogen bond donors | 9 |
| Rotatable bonds | 17 |
| Molecular weight (Da) | 1046.5 |
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| SST1 | SSR1 | Human | Somatostatin | A | pKi | 8.2 | 8.2 | 8.2 | ChEMBL |
| SST2 | SSR2 | Human | Somatostatin | A | pKi | 9.0 | 9.0 | 9.0 | ChEMBL |
| SST3 | SSR3 | Human | Somatostatin | A | pKi | 9.1 | 9.1 | 9.1 | ChEMBL |
| SST5 | SSR5 | Human | Somatostatin | A | pKi | 9.9 | 9.9 | 9.9 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| SST2 | SSR2 | Rat | Somatostatin | A | pEC50 | 7.76 | 7.01 | 9.07 | Guide to Pharmacology |
| SST1 | SSR1 | Human | Somatostatin | A | pIC50 | 8.0 | 8.0 | 8.0 | Guide to Pharmacology |
| SST2 | SSR2 | Human | Somatostatin | A | pIC50 | 9.0 | 9.0 | 9.0 | Guide to Pharmacology |
| SST3 | SSR3 | Human | Somatostatin | A | pIC50 | 8.8 | 8.8 | 8.8 | Guide to Pharmacology |
| SST5 | SSR5 | Human | Somatostatin | A | pIC50 | 9.8 | 9.8 | 9.8 | Guide to Pharmacology |
| SST2 | SSR2 | Rat | Somatostatin | A | pEC50 | 8.04 | 8.04 | 8.04 | Drug Central |
| SST1 | SSR1 | Human | Somatostatin | A | pIC50 | 8.1 | 8.1 | 8.1 | Drug Central |
| SST2 | SSR2 | Human | Somatostatin | A | pIC50 | 8.05 | 8.05 | 8.05 | Drug Central |
| SST3 | SSR3 | Human | Somatostatin | A | pIC50 | 8.06 | 8.06 | 8.06 | Drug Central |
| SST5 | SSR5 | Human | Somatostatin | A | pIC50 | 8.01 | 8.01 | 8.01 | Drug Central |